Blog & Resources Camargo Blog June 14th, 2017

A Green Card Is No Longer a “Green Light”—Changes to FDA Security Policy

Changes to FDA Security Policy

If you have been to a meeting at the FDA recently, you may have experienced the roller coaster that is their parking/visitor drop-off policy. There have been so many changes that FDA project managers have taken to including specific instructions in the “Meeting Granted” letter. But the fun doesn’t stop there – this is not the only policy that’s changing as part of new security measures being adopted by the Agency.

We were recently notified that permanent US residents (i.e., “green card” holders) are now considered foreign visitors and must be screened in advance of a visit. This means is that green card holders must now complete and submit the “Foreign Visitor Request” form along with non-US citizens. This form is typically attached to the “Meeting Granted” letter, and must be submitted no later than 2 weeks prior to your meeting date. Failure to do so means you will get to sit in the lobby during your meeting (at least the chairs are reasonably comfy!).

As part of Camargo’s comprehensive meeting preparation, we take care of administrative details such as this, so that you can focus your attention on the bigger stuff.

Contact us to learn more about the many ways Camargo can bring value to your drug development program.

Author: Karen Seta-Aust, PhD, Director of Scientific and Regulatory Affairs, Camargo Pharmaceutical Services

Categories: Regulatory

Get Our Expertise Working for You

To learn how you can benefit from our regulatory and strategic development expertise, view our solutions or contact us.

Camargo Pharmaceutical Services provides comprehensive drug development solutions, specializing in customized programs including the 505(b)(2) pathway.

9825 Kenwood Road
Suite 203
Cincinnati OH, 45242
Durham Office
800 Taylor Street
Suite 101
Durham NC, 27701
Montreal Office
507 Place d'Armes
Suite 1101
Montreal, QC H2Y 2W8, Canada
Phone 513.561.3329
Toll Free 888.451.5708
Subscribe for our Latest Insights